Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Primary immunodeficiencies and the control of Epstein-Barr virus infection.

Palendira U, Rickinson AB.

Ann N Y Acad Sci. 2015 Nov;1356:22-44. doi: 10.1111/nyas.12937. Epub 2015 Sep 28. Review.

PMID:
26415106
2.

X-linked lymphoproliferative syndrome. Natural history of the immunodeficiency.

Sullivan JL, Byron KS, Brewster FE, Baker SM, Ochs HD.

J Clin Invest. 1983 Jun;71(6):1765-78.

3.

Primary immunodeficiencies predisposed to Epstein-Barr virus-driven haematological diseases.

Parvaneh N, Filipovich AH, Borkhardt A.

Br J Haematol. 2013 Sep;162(5):573-86. doi: 10.1111/bjh.12422. Epub 2013 Jun 11. Review.

PMID:
23758097
4.

X-linked lymphoproliferative syndromes and related autosomal recessive disorders.

Veillette A, Pérez-Quintero LA, Latour S.

Curr Opin Allergy Clin Immunol. 2013 Dec;13(6):614-22. doi: 10.1097/ACI.0000000000000008. Review.

PMID:
24113228
5.

Immunopathology of the X-linked lymphoproliferative syndrome.

Purtilo DT.

Haematol Blood Transfus. 1981;26:207-14.

PMID:
6274747
6.

Cellular responses to viral infection in humans: lessons from Epstein-Barr virus.

Hislop AD, Taylor GS, Sauce D, Rickinson AB.

Annu Rev Immunol. 2007;25:587-617. Review.

PMID:
17378764
7.

Role of human natural killer cells during Epstein-Barr virus infection.

Münz C.

Crit Rev Immunol. 2014;34(6):501-7. Review.

PMID:
25597312
8.

Cellular immune defects to Epstein-Barr virus-determined antigens in young males.

Masucci MG, Szigeti R, Ernberg I, Masucci G, Klein G, Chessels J, Sieff C, Lie S, Glomstein A, Businco L, Henle W, Henle G, Pearson G, Sakamoto K, Purtilo DT.

Cancer Res. 1981 Nov;41(11 Pt 1):4284-91.

9.

Immunodeficiency as a factor in lymphomagenesis.

Purtilo DT, Sakamoto K.

Perspect Pediatr Pathol. 1984 Summer;8(2):181-91.

PMID:
6330665
10.

Cell-mediated immune responses in man to Epstein-Barr (EB) virus infection.

Lai PK, Alpers MP.

Comp Immunol Microbiol Infect Dis. 1979;2(4):565-85. Review. No abstract available.

PMID:
232867
11.

Epstein-Barr-virus-induced oncogenesis in immune-deficient individuals.

Purtilo DT.

Lancet. 1980 Feb 9;1(8163):300-3.

PMID:
6101750
12.

The relationship between Epstein-Barr virus and lymphoma.

Bird AG, Britton S.

Semin Hematol. 1982 Oct;19(4):285-300. Review. No abstract available.

PMID:
6297094
13.

Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.

Borysiewicz LK, Haworth SJ, Cohen J, Mundin J, Rickinson A, Sissons JG.

Q J Med. 1986 Feb;58(226):111-21.

PMID:
3012622
14.

Epstein-Barr virus: a human pathogen inducing lymphoproliferation in vivo and in vitro.

Sugden B.

Rev Infect Dis. 1982 Sep-Oct;4(5):1048-61. Review.

PMID:
6293034
15.

[The Epstein-Barr virus infects immunologic cells].

Ernberg I, Britton S.

Lakartidningen. 1983 Feb 23;80(8):689-92. Swedish. No abstract available.

PMID:
6306366
17.

Induction and progression of human lymphoproliferative lesions by Epstein-Barr virus.

Chappuis BB, Müller-Hermelink HK.

Environ Health Perspect. 1990 Aug;88:237-41.

18.

Primary Immunodeficiencies Associated with EBV Disease.

Cohen JI.

Curr Top Microbiol Immunol. 2015;390(Pt 1):241-65. doi: 10.1007/978-3-319-22822-8_10. Review.

PMID:
26424649
19.

Epstein-Barr virus and the X-linked lymphoproliferative syndrome.

Sullivan JL.

Adv Pediatr. 1983;30:365-99. Review. No abstract available.

PMID:
6324556
20.

Supplemental Content

Support Center